CAROLINA VALERIO BARROS
Projetos de Pesquisa
Unidades Organizacionais
2 resultados
Resultados de Busca
Agora exibindo 1 - 2 de 2
conferenceObject Psychiatric Comorbidity in Patients with Ocd: Implications for Treatment Response After One Year Follow-Up(2012) SENCO, Natasha M.; FOSSALUZA, Victor; VALERIO, Carolina; DINIZ, Juliana B.; MIGUEL, Euripedes C.; SHAVITT, Roselli G.Background: The present study aimed to investigate, prospectively, clinical and socio-demographic features that may influence response to OCD treatment in the long term. Methods: One hundred ninety-seven subjects, who received randomized treatment with group cognitive behavioral therapy (GCBT) or a selective serotonin reuptake inhibitor (SSRI) for the first 12 weeks have been studied. Non-responders to the initial treatment had their treatment tailored to individual conditions, according to international guidelines for the treatment of OCD. Treatment response, measured initially and after three, six and twelve months, was considered as a categorical [35% or greater reduction in baseline YBOCS scores plus a CGI-Improvement rating of better(2) or much better(1)] and as a continuous variable (percent reduction in baseline YBOCS scores). Results: After one year follow-up, better treatment response were associated with absence of psychiatric comorbidity (p= 0,0002) and, in particular, absence of a mood disorder (p=0,0004). Poorer outcome was associated to higher scores on Beck Depression Inventory (p=0,0012), number of psychiatric comorbidities (p=0,0015) and presence of obsessive thoughts of diverse content (p= 0,0117). Age at onset, male gender and family history of OCD were not associated with treatment response in this sample, and there was no influence of initial treatment modality on the long-term outcome. Conclusions: In this study, comorbidity number showed correlation with poorer treatment response. Additional studies will be necessary to enlighten if there is an early set point to determine treatment success or failure.conferenceObject Can Early Improvement be an Indicator of Treatment Response at Twelve Weeks in Obsessive Compulsive Disorder? Implications for Early-Treatment Decision-Making(2012) COSTA, Daniel L. C.; DINIZ, Juliana B.; JOAQUIM, Marines; BORCATO, Sonia R.; VALERIO, Carolina; MIGUEL, Euripedes C.; SHAVITT, Roseli G.Background: Delayed onset of response to serotonin reuptake inhibitors represents a challenge in obsessive-compulsive disorder (OCD) treatment. In depression, absence of improvement in the first weeks has been raised as a motive to switch antidepressants before full non-response is observed. We aimed to investigate if early improvement is a predictor of OCD outcome after 12 weeks. Methods: Participants (n=150) were admitted to a specialized OCD outpatient program. Inclusion criteria: age 18-65, DSM-IV diagnosis of OCD, minimum baseline Yale-Brown Obsessive Compulsive Scale(Y-BOCS) score of 16, absence of previous pharmacological treatment for OCD. Fluoxetine was used up to 80mg/day. Systematic assessments were taken at baseline, weeks 4 and 12. Non-improvement at 4-weeks was defined as no reduction of baseline Y-BOCS scores. Response at 12 weeks was defined as 35% or greater decrease in baseline Y-BOC score. Spearman correlation, linear regression and chi-square test were performed to test the relationship between improvement at 4-weeks and the 12-weeks outcome. Results: Mean Y-BOCS scores(SD) at baseline, 4 and 12 weeks were, respectively: 27.3(5.4), 22.8(6.9) and 20.8(8.3). Correlation coefficient for 4-weeks improvement and 12-weeks outcome was 0.43(p=0.01). Linear regression analysis showed no-effect of the covariates on 12-weeks outcome and confirmed the relationship between improvement at 4-weeks and outcome at 12 weeks (β coef= 0.44, p< 0.01). Only five (11.9%) non-responders at 4-weeks were responders at 12-weeks (Pearson Chi-Square= 9.1, p= 0.003). Conclusions: Early improvement predicted 12-weeks outcome of OCD, which may have a role in early decision-making in OCD treatment.